http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107519216-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d09f1d32f6494531c696ea59219b0d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-09
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e02445393ff7395c7e56add1124020d8
publicationDate 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107519216-A
titleOfInvention Blood-snow tea antitumor active site and preparation method and application
abstract The present invention relates to a kind of blood-snow tea antitumor active site and preparation method and application, belong to medicinal plants technical field.Blood-snow tea antitumor active site of the present invention is to use lichens blood-snow tea as raw material, is detected with reference to antitumor activity, the multiple mixtures with conspicuousness antitumor action being prepared;With obvious cell targeted, selective antitumor action, have with clinical antineoplastic chemotherapeutics and cooperate with or be added antitumor action, energy conspicuousness promotes apoptosis of tumor cells, the period profile for influenceing tumour cell, suppresses tumor cell proliferation.Larger difference be present in the antitumor action at different activities position.Blood-snow tea antitumor active site can be made into various preparations and use, and can be used as antineoplastic, joint antineoplastic, adjunct antineoplastic health products, have a good application prospect.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109867657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109867657-B
priorityDate 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453007711
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2054047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2054047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22609514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10095

Total number of triples: 44.